Triazolam - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for triazolam and what is the scope of freedom to operate?

Triazolam is the generic ingredient in two branded drugs marketed by Pfizer, Hikma, Norvium Bioscience, Novast Labs, Sandoz, Watson Labs, and Zydus Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for triazolam. Nine suppliers are listed for this compound.

Summary for triazolam

US Patents:	0
Tradenames:	2
Applicants:	7
NDAs:	7
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	37
Clinical Trials:	19
Patent Applications:	6,564
Drug Prices:	Drug price trends for triazolam
What excipients (inactive ingredients) are in triazolam?	triazolam excipients list
DailyMed Link:	triazolam at DailyMed

See drug prices for triazolam

See drug sales revenues for triazolam

Recent Clinical Trials for triazolam

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
RenJi Hospital	Phase 4
University of Manitoba	N/A
Rocky Vista University, LLC	Phase 4

See all triazolam clinical trials

Pharmacology for triazolam

Drug Class	Benzodiazepine

Medical Subject Heading (MeSH) Categories for triazolam

Adjuvants, Anesthesia
Anti-Anxiety Agents
GABA Modulators

Anatomical Therapeutic Chemical (ATC) Classes for triazolam

N05CD	Benzodiazepine derivatives
N05C	HYPNOTICS AND SEDATIVES
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for triazolam

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz	TRIAZOLAM	triazolam	TABLET;ORAL	216890-001	Nov 8, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novast Labs	TRIAZOLAM	triazolam	TABLET;ORAL	214219-002	Oct 20, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	TRIAZOLAM	triazolam	TABLET;ORAL	074031-001	Mar 25, 1994		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for triazolam

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	HALCION	triazolam	TABLET;ORAL	017892-003	Apr 26, 1985	⤷ Sign Up	⤷ Sign Up
Pfizer	HALCION	triazolam	TABLET;ORAL	017892-001	Nov 15, 1982	⤷ Sign Up	⤷ Sign Up
Pfizer	HALCION	triazolam	TABLET;ORAL	017892-002	Nov 15, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.